3 sources • 4 verified points
Cosmetics Companies Test Treatments for "Ozempic Face" as Obesity Drug Market Grows
Major cosmetics companies, including Switzerland's Galderma, Brazil's Natura and L'Oréal, are testing treatments for consumers worried about facial sagging and loss of volume after rapid weight loss, known as "Ozempic face." This comes as the obesity drug market grows, and coverage indicates that creams have limited effect and that injections are better for restoring volume.
AI-written summary of 3 sources; every verified point is backed by a verbatim quote. How Iyan works
- Companies testing the treatments include Switzerland's Galderma for skincare, Brazil's Natura for cosmetics, and L'Oréal.
«تختبر شركات جالديرما السويسرية للعناية بالبشرة وناتورا البرازيلية لمستحضرات التجميل ولوريال العملاقة في مجال التجميل، علاجات للمستهلكين القلقين»
المشهد - The treatments are aimed at consumers worried about facial sagging and loss of volume.
«علاجات للمستهلكين القلقين من ترهل وفقدان ح»
المشهد - These tests come as the obesity drug market grows, and the companies are targeting users of weight-loss drugs.
«شركات التجميل تستهدف مستخدمي أدوية التخسيس»
صحيفة الخليج • الشرق للأخبار - Creams have limited effect, and injections are better for restoring lost volume.
«الكريمات محدودة والحقن أفضل لاستعادة الحجم»
صحيفة الخليج
Iyan — See it for yourself. What changed in your world today, why it matters, and how we know.
How it works • Privacy • Terms